| FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension - PR Newswire (press release) |
|
|
PR Newswire (press release) Monitor for worsening renal function in patients with renal impairment. In patients whose renal function may depend on the activity of the renin-angiotensin system, treatment with ACE inhibitors and ARBs has been associated with oliguria or progressive |